Anita Bringmann

899 total citations
20 papers, 771 citations indexed

About

Anita Bringmann is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Anita Bringmann has authored 20 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Anita Bringmann's work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers) and Immune Response and Inflammation (6 papers). Anita Bringmann is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers) and Immune Response and Inflammation (6 papers). Anita Bringmann collaborates with scholars based in Germany, United States and Switzerland. Anita Bringmann's co-authors include Peter Brossart, Frank Grünebach, Markus M. Weck, Silke Appel, Daniela Werth, Annkristin Heine, Christian Sinzger, Stefanie Andrea Erika Held, Tobias A.W. Holderried and Katharina M. Brauer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Anita Bringmann

20 papers receiving 758 citations

Peers

Anita Bringmann

IMMUN

ONCOL

HEMAT

Takeshi Otani Japan

Constantinos Georganas United States

Hiroyoshi Hattori Japan

Chuen-Miin Leu Taiwan

Krzysztof Grzegorzewski United States

Brian Crain United States

Nathan D. Mathewson United States

Kazuto Tsuruda Japan

Jane M. Turbov United States

S Visonneau United States

Takeshi Otani Japan

Anita Bringmann

411 ×0.8

IMMUN

316 ×1.1

180 ×1.0

ONCOL

61 ×0.7

58 ×0.7

HEMAT

Citations per year, relative to Anita Bringmann Anita Bringmann (= 1×) peers Takeshi Otani

Countries citing papers authored by Anita Bringmann

Since Specialization

Citations

This map shows the geographic impact of Anita Bringmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Bringmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Bringmann more than expected).

Fields of papers citing papers by Anita Bringmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita Bringmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Bringmann. The network helps show where Anita Bringmann may publish in the future.

Co-authorship network of co-authors of Anita Bringmann

This figure shows the co-authorship network connecting the top 25 collaborators of Anita Bringmann. A scholar is included among the top collaborators of Anita Bringmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita Bringmann. Anita Bringmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mildner, Alexander, Elik Chapnik, Diana Varol, et al.. (2017). MicroRNA‐142 controls thymocyte proliferation. European Journal of Immunology. 47(7). 1142–1152. 31 indexed citations

Held, Stefanie Andrea Erika, et al.. (2015). Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma. Experimental Hematology and Oncology. 4(1). 21–21. 29 indexed citations

Held, Stefanie Andrea Erika, Stefan Tenzer, Thomas Rückrich, et al.. (2012). Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides. Cancer Immunology Immunotherapy. 62(4). 715–726. 6 indexed citations

Heine, Annkristin, et al.. (2011). Immunomodulatory effects of anti-angiogenic drugs. Leukemia. 25(6). 899–905. 62 indexed citations

Bringmann, Anita, et al.. (2011). Regulation of dectin-1–mediated dendritic cell activation by peroxisome proliferator–activated receptor-gamma ligand troglitazone. Blood. 117(13). 3569–3574. 26 indexed citations

Bringmann, Anita, Stefanie Andrea Erika Held, Annkristin Heine, & Peter Brossart. (2010). RNA Vaccines in Cancer Treatment. SHILAP Revista de lepidopterología. 2010. 1–12. 32 indexed citations

Schmidt, Susanne M., Thomas König, Anita Bringmann, et al.. (2009). Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen. Leukemia. 23(10). 1818–1824. 10 indexed citations

Schwarzenberg, Karin von, et al.. (2009). Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARγ ligand troglitazone. Cellular and Molecular Life Sciences. 66(7). 1295–1308. 10 indexed citations

Schmidt, Sebastian, Anita Bringmann, Markus M. Weck, et al.. (2008). Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells. Leukemia. 23(3). 535–544. 31 indexed citations

10.

Baltz, Katrin M., Matthias Krusch, Tina Baessler, et al.. (2008). Neutralization of tumor-derived soluble Glucocorticoid-Induced TNFR-Related Protein ligand increases NK cell anti-tumor reactivity. Blood. 112(9). 3735–3743. 44 indexed citations

11.

Krusch, Matthias, Katrin M. Baltz, Anita Bringmann, Peter Brossart, & Helmut R. Salih. (2008). Tumor‐derived soluble Glucocorticoid‐Induced TNF‐Related Protein (GITR) ligand diminishes anti‐tumor reactivity of NK cells. The FASEB Journal. 22(S1). 1 indexed citations

12.

Bringmann, Anita, Sebastian Schmidt, Markus M. Weck, et al.. (2007). Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells. Leukemia. 21(4). 732–738. 30 indexed citations

13.

Weck, Markus M., Frank Grünebach, Daniela Werth, et al.. (2007). TLR ligands differentially affect uptake and presentation of cellular antigens. Blood. 109(9). 3890–3894. 81 indexed citations

14.

Brauer, Katharina M., Daniela Werth, Karin von Schwarzenberg, et al.. (2007). BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells. Cancer Research. 67(11). 5489–5497. 41 indexed citations

15.

Weck, Markus M., Silke Appel, Daniela Werth, et al.. (2007). hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood. 111(8). 4264–4272. 68 indexed citations

16.

Baltz, Katrin M., Matthias Krusch, Tina Baessler, et al.. (2007). Neutralization of Tumor-Derived Soluble Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand Present in Cancer Patient Sera Increases Anti-Tumor Reactivity of NK Cells.. Blood. 110(11). 314–314. 2 indexed citations

17.

Baltz, Katrin M., Matthias Krusch, Anita Bringmann, et al.. (2007). Cancer immunoediting by GITR (glucocorticoid‐induced TNF‐related protein) ligand in humans: NK cell/tumor cell interactions. The FASEB Journal. 21(10). 2442–2454. 86 indexed citations

18.

Brauer, Katharina M., Daniela Werth, Karin von Schwarzenberg, et al.. (2006). BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells.. Blood. 108(11). 2202–2202. 1 indexed citations

19.

Appel, Silke, Anita Bringmann, Frank Grünebach, et al.. (2005). Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs. Blood. 107(8). 3265–3270. 17 indexed citations

20.

Appel, Silke, et al.. (2005). PPAR-γ agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-κB pathways. Blood. 106(12). 3888–3894. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact